Full text is available at the source.
Abstract
The frequency of glucagon-like peptide-1 receptor agonist (GLP-1RA) discontinuation after hospitalization for bowel obstruction or ileus is examined.
- Concerns exist that GLP-1RAs may be linked to increased risks of bowel obstruction or ileus.
- Evidence regarding the relationship between GLP-1RAs and bowel obstruction/ileus remains inconclusive.
- The study investigates the reasons behind the discontinuation of GLP-1RAs following hospitalization for these conditions.
- Determinants of GLP-1RA discontinuation are explored in the context of recent hospitalizations.
Simplified